Horizon Therapeutics Publ... (HZNP)
NASDAQ: HZNP
· Real-Time Price · USD
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Horizon Therapeutics Public Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.46B | 2.31B | 2.35B | 2.13B | 1.89B | 1.64B | 1.58B | 1.07B | 812.32M | 811.61M |
Short-Term Investments | 31.89M | 29.52M | 28.23M | 25.11M | n/a | 28.38M | 26.52M | n/a | 23.89M | 21.71M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 263.04M | 187.81M | 204.13M | 203.61M | 160.62M | 162.46M | 140.74M | 125.91M | 132.59M | 57.16M |
Receivables | 717.42M | 630.06M | 676.35M | 646.39M | 673.31M | 684.51M | 632.77M | 775.37M | 735.43M | 443.17M |
Inventory | 170.32M | 164.5M | 169.56M | 190.26M | 203.68M | 226.52M | 225.73M | 237.43M | 258.68M | 238.31M |
Other Current Assets | 564.81M | 115.97M | 449.35M | 419.73M | 25.59M | 393.57M | 360.94M | 24.37M | 368.95M | 338.28M |
Total Current Assets | 3.92B | 3.6B | 3.65B | 3.41B | 3.2B | 2.95B | 2.8B | 2.41B | 2.18B | 1.83B |
Property-Plant & Equipment | 362.33M | 355.87M | 340.51M | 317.69M | 302.26M | 295.15M | 292.3M | 285.84M | 220.14M | 201.86M |
Goodwill & Intangibles | 4.31B | 4.4B | 4.49B | 4.58B | 4.67B | 4.82B | 4.91B | 5B | 5.07B | 5.17B |
Total Long-Term Assets | 5.38B | 5.39B | 5.46B | 5.62B | 5.65B | 5.79B | 5.88B | 6.19B | 6.03B | 6.02B |
Total Assets | 9.3B | 8.99B | 9.11B | 9.03B | 8.85B | 8.74B | 8.68B | 8.61B | 8.21B | 7.85B |
Account Payables | 85.54M | 76.62M | 155.8M | 32.11M | 18.54M | 67.01M | 30.13M | 50.72M | 51.95M | 42.99M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.35M | 20.84M | n/a |
Short-Term Debt | 16M | 16M | 16M | 16M | 16M | 16M | 16M | 16M | 16M | 16M |
Other Current Liabilities | 816.14M | 792.27M | 777.34M | 812.5M | 756.52M | 742.16M | 840.45M | 787.32M | 784.86M | 714.86M |
Total Current Liabilities | 917.68M | 884.89M | 949.14M | 860.61M | 791.06M | 825.18M | 886.57M | 854.04M | 852.81M | 773.84M |
Long-Term Debt | 2.54B | 2.54B | 2.55B | 2.55B | 2.55B | 2.55B | 2.56B | 2.56B | 2.56B | 2.56B |
Other Long-Term Liabilities | 263.83M | 197.22M | 204.45M | 199.3M | 199.65M | 209.81M | 173.08M | 155.01M | 171.45M | 131.07M |
Total Long-Term Liabilities | 3.07B | 3.01B | 3.09B | 3.13B | 3.12B | 3.1B | 3.12B | 3.3B | 3.28B | 3.22B |
Total Liabilities | 3.99B | 3.9B | 4.04B | 3.99B | 3.91B | 3.92B | 4.01B | 4.16B | 4.13B | 3.99B |
Total Debt | 2.56B | 2.56B | 2.56B | 2.57B | 2.57B | 2.57B | 2.57B | 2.57B | 2.58B | 2.58B |
Common Stock | 23K | 23K | 23K | 23K | 23K | 23K | 23K | 22K | 22K | 22K |
Retained Earnings | 771.76M | 644.69M | 590.01M | 606.28M | 583.84M | 522.87M | 318.61M | 145.42M | -181.12M | -339.24M |
Comprehensive Income | 21.61M | 6.68M | 12.53M | 7.46M | -15.09M | -15.12M | -14.99M | -1.53M | -1.02M | -1.25M |
Shareholders Equity | 5.31B | 5.1B | 5.07B | 5.03B | 4.95B | 4.82B | 4.67B | 4.45B | 4.07B | 3.85B |
Total Investments | 31.89M | 29.52M | 28.23M | 25.11M | n/a | 28.38M | 26.52M | n/a | 23.89M | 21.71M |